軟骨修復/軟骨再生市場：治療モード、用途、エンドユーザー別- 世界予測2024-2030年

軟骨修復/軟骨再生市場規模は2023年に18億3,000万米ドルと推定され、2024年には20億6,000万米ドルに達し、CAGR 13.55％で2030年には44億6,000万米ドルに達すると予測されます。

軟骨の修復と再生とは、損傷した関節軟骨の機能回復と痛みの緩和を目的とした、さまざまな医学的治療と処置を指します。軟骨は弾力性のある滑らかな弾性組織です。このゴムのようなパッドは、関節の長い骨の端を覆って保護し、胸郭、耳、鼻、気管支、椎間板、その他多くの身体の構成要素となっています。軟骨修復・再生市場には、損傷した軟骨の修復、再生、置換を目的とした医療処置、ツール、治療法が含まれます。関節炎や変形性関節症などの骨・関節疾患の蔓延、交通事故やスポーツ関連傷害の急増が市場成長の原動力となっています。また、軟骨の生理学、解剖学、修復技術に関する意識の高まりも、市場の燃料となっています。軟骨修復手術に伴う費用や、軟骨修復・再生手術に伴うリスクや合併症が市場開拓を制限しています。軟骨再生機器の技術的進歩は、再生治療の有効性を高めています。さらに、軟骨再生のための継続的な研究開発が、その成長可能性を拡大しています。

治療モード若年患者には細胞ベースの治療法が好まれる

細胞療法は、生きた細胞を用いて軟骨組織を修復・再生するものです。これらの治療法では、軟骨細胞に分化できる軟骨細胞や間葉系幹細胞を利用することが多いです。細胞を用いた軟骨細胞移植は、軟骨の欠損や損傷に対する先進医療であり、通常、局所的に軟骨が欠損している患者に用いられます。このプロセスでは、患者の体内から健康な軟骨細胞を採取し、実験室内でこれらの細胞を増殖させ、その後損傷部位に再移植します。成長因子技術では、軟骨細胞を含む細胞の成長と分化を促進することが知られている特定のタンパク質を適用します。これらの生物学的分子は、注射や足場への埋め込みなど、さまざまな方法で投与することができます。一方、細胞を用いない治療法には、軟骨の自然な修復過程を助ける組織足場や成長因子など、生きた細胞を直接用いない治療法があります。無細胞複合材料は、生きた細胞を直接使うことなく軟骨組織の再生を可能にする生体材料です。その代わりに、これらの材料は細胞外マトリックスを模倣し、欠損部位への生来の細胞の移動と増殖をサポートするように設計されています。組織足場は、新しい軟骨組織の成長と発達のための支持環境を提供する3次元構造体です。これらの足場は、生分解性または非生分解性であり、天然ポリマーや合成ポリマー、セラミック、複合材料など、さまざまな材料から作られます。

応用効率的な関節運動のためのヒアリン軟骨療法の普及

線維軟骨は、椎間板、半月板、恥骨結合などの体の部位に見られる、強靭で緻密な繊維状の軟骨組織です。白色の線維組織と軟骨組織が様々な割合で混在しているのが特徴です。線維軟骨はその高い引っ張り強度と限られた血液供給量のために、内在的な治癒能力には限界があり、そのため特殊な修復技術の開発が必要とされています。ヒアルロン酸軟骨は透明で光沢のある関節軟骨で、関節の骨を保護しています。関節の動きに滑らかで摩擦の少ない表面を提供し、荷重を効果的に分散するのに役立っています。ヒアルロン酸軟骨の損傷は、関節の痛み、こわばり、変形性関節症などの症状を引き起こします。その無血管性という性質は、修復と再生に大きな課題をもたらします。線維軟骨とヒアルロン酸軟骨の修復を比較すると、解剖学的および機能的な違いから、両者とも異なるアプローチが必要であることがわかる。線維軟骨はより繊維性が強く、体のより少ない部位にしか存在しないが、ヒアルロン酸軟骨はすべての滑膜関節に広く存在し、関節機能にとって重要です。線維軟骨の損傷は、多くの関節に影響を及ぼす可能性のあるヒアルロン酸軟骨の問題ではなく、膝や骨盤のような特定の部位に関連するのが一般的です。

エンドユーザー：複雑な処置に必要な高度な機器や材料が存在するため、病院での軟骨修復/軟骨再生の適用が増加しています。

外来手術センター（ASCs）は、診断や予防処置を含む外科治療を即日提供するヘルスケア施設です。軟骨修復と再生において、ASCはその費用対効果と利便性から、患者にとってますます人気のある選択肢となっています。整形外科やスポーツ医学クリニックなどの専門クリニックも含め、外来での軟骨修復・再生サービスを提供しています。このような施設では、病院よりも規模が小さいため、患者のケアに対してより個別的なアプローチを提供することが多いです。病院は、高度な軟骨修復・再生に必要な複雑な手術を含む、幅広い医療サービスを提供する総合医療施設です。外来手術センターは軽度の処置に効率的で費用対効果の高いソリューションを提供し、クリニックは個別化された非侵襲的な治療を提供し、病院は包括的なケアと複雑な手術に対応しています。プロバイダーとメーカーのコラボレーションは、技術の進歩を促進し、これらすべてのヘルスケア環境における患者の転帰を改善し続けています。

地域別の洞察

米国は、確立された医療インフラ、有利な償還シナリオ、主要市場プレイヤーの存在により、革新的な軟骨修復ソリューションの採用で地域をリードしています。ブラジルやメキシコなどの国々も、ヘルスケア環境におけるリソースの制限や償還環境の不利といった課題はあるもの、市場成長の可能性を示しています。アジア太平洋地域は、軟骨修復・再生の重要なプレーヤーとして急速に台頭しつつあります。この成長を後押ししているのは、可処分所得の増加、ヘルスケア部門の拡大、軟骨再生術に対する意識の高まり、生活習慣に関連した関節障害の有病率の上昇などです。欧州はEMEA軟骨修復・再生市場の主要地域であり、洗練されたヘルスケアシステム、高額な医療費、強力な規制枠組みに支えられています。大手ヘルスケア企業の存在と研究開発への多額の投資が、軟骨修復療法の技術革新を促進しています。一方、中東とアフリカは、ヘルスケアへのアクセスと質の格差が大きく、成長が鈍化しています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは軟骨修復/軟骨再生市場を評価する上で極めて重要です。事業戦略や製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、軟骨修復/軟骨再生市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2.市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3.市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4.競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力について徹底的な評価を行います。

5.製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1.軟骨修復/軟骨再生市場の市場規模および予測は？

2.軟骨修復/軟骨再生市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3.軟骨修復/軟骨再生市場の技術動向と規制枠組みは？

4.軟骨修復/軟骨再生市場における主要ベンダーの市場シェアは？

5.軟骨修復/軟骨再生市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 関節炎や変形性関節症などの骨や関節の疾患の有病率
    • 交通事故やスポーツ関連の負傷件数が急増
    • 軟骨の生理学、解剖学、修復技術に関する意識の高まり
  • 抑制要因
    • 軟骨修復手術に伴う高額な費用
  • 機会
    • 軟骨再生装置の技術的進歩
    • 軟骨再生のための継続的な研究開発
  • 課題
    • 軟骨修復/軟骨再生処置に伴うリスクと合併症
• 市場セグメンテーション分析
  • 治療モード：若年患者には細胞ベースの治療法が優先される
  • 応用：効率的な関節運動のための硝子軟骨療法のより広範な利用
  • エンドユーザー：複雑な手順に必要な高度な機器や材料が存在するため、病院環境での軟骨修復/軟骨再生の適用が増加しています。
• 市場ディスラプション分析
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 価格分析
• 技術分析
• 特許分析
• 貿易分析
• 規制枠組みの分析

第6章 軟骨修復/軟骨再生市場治療モード別

• 細胞ベース
• 非細胞ベース

第7章 軟骨修復/軟骨再生市場：用途別

• 線維軟骨
• 硝子軟骨

第8章 軟骨修復/軟骨再生市場：エンドユーザー別

• 外来手術センター
• クリニック
• 病院

第9章 南北アメリカの軟骨修復/軟骨再生市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の軟骨修復/軟骨再生市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの軟骨修復/軟骨再生市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス、2023
• 競合シナリオ分析
  • スミス・ネフュー、スポーツ医学の膝修復のための新しい軟骨再生技術を取得
  • FDAが軟骨および骨軟骨欠損の治療にCartiHealのインプラントを承認
• 戦略分析と提言

第13章 競争力のあるポートフォリオ

• 主要企業プロファイル
• 主要製品ポートフォリオ

LIST OF FIGURES

• FIGURE 1. CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET RESEARCH PROCESS
• FIGURE 2. CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY REGION, 2023 VS 2030 (%)
• FIGURE 5. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET DYNAMICS
• FIGURE 7. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2023 VS 2030 (%)
• FIGURE 8. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 9. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 10. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 11. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 12. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 13. AMERICAS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 14. AMERICAS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 15. UNITED STATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 16. UNITED STATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 17. ASIA-PACIFIC CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 18. ASIA-PACIFIC CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 21. CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 22. CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, 2018-2023 (USD MILLION)
• TABLE 4. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, 2024-2030 (USD MILLION)
• TABLE 5. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 6. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 7. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2023 (USD MILLION)
• TABLE 8. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2024-2030 (USD MILLION)
• TABLE 9. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, BY REGION, 2018-2023 (USD MILLION)
• TABLE 10. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, BY REGION, 2024-2030 (USD MILLION)
• TABLE 11. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2023 (USD MILLION)
• TABLE 12. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2024-2030 (USD MILLION)
• TABLE 13. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CHONDROCYTE TRANSPLANTATION, BY REGION, 2018-2023 (USD MILLION)
• TABLE 14. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CHONDROCYTE TRANSPLANTATION, BY REGION, 2024-2030 (USD MILLION)
• TABLE 15. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY GROWTH FACTOR TECHNOLOGY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 16. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY GROWTH FACTOR TECHNOLOGY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 17. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, BY REGION, 2018-2023 (USD MILLION)
• TABLE 18. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, BY REGION, 2024-2030 (USD MILLION)
• TABLE 19. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2023 (USD MILLION)
• TABLE 20. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2024-2030 (USD MILLION)
• TABLE 21. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-FREE COMPOSITES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 22. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-FREE COMPOSITES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 23. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TISSUE SCAFFOLDS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 24. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TISSUE SCAFFOLDS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 25. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 26. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 27. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY FIBROCARTILAGE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 28. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY FIBROCARTILAGE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 29. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY HYALINE CARTILAGE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 30. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY HYALINE CARTILAGE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 31. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 32. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 33. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 34. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 35. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CLINICS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 36. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CLINICS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 37. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 38. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 39. AMERICAS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2023 (USD MILLION)
• TABLE 40. AMERICAS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2024-2030 (USD MILLION)
• TABLE 41. AMERICAS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2023 (USD MILLION)
• TABLE 42. AMERICAS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2024-2030 (USD MILLION)
• TABLE 43. AMERICAS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2023 (USD MILLION)
• TABLE 44. AMERICAS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2024-2030 (USD MILLION)
• TABLE 45. AMERICAS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 46. AMERICAS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 47. AMERICAS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 48. AMERICAS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 49. AMERICAS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 50. AMERICAS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 51. ARGENTINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2023 (USD MILLION)
• TABLE 52. ARGENTINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2024-2030 (USD MILLION)
• TABLE 53. ARGENTINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2023 (USD MILLION)
• TABLE 54. ARGENTINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2024-2030 (USD MILLION)
• TABLE 55. ARGENTINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2023 (USD MILLION)
• TABLE 56. ARGENTINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2024-2030 (USD MILLION)
• TABLE 57. ARGENTINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 58. ARGENTINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 59. ARGENTINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 60. ARGENTINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 61. BRAZIL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2023 (USD MILLION)
• TABLE 62. BRAZIL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2024-2030 (USD MILLION)
• TABLE 63. BRAZIL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2023 (USD MILLION)
• TABLE 64. BRAZIL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2024-2030 (USD MILLION)
• TABLE 65. BRAZIL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2023 (USD MILLION)
• TABLE 66. BRAZIL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2024-2030 (USD MILLION)
• TABLE 67. BRAZIL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 68. BRAZIL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 69. BRAZIL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 70. BRAZIL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 71. CANADA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2023 (USD MILLION)
• TABLE 72. CANADA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2024-2030 (USD MILLION)
• TABLE 73. CANADA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2023 (USD MILLION)
• TABLE 74. CANADA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2024-2030 (USD MILLION)
• TABLE 75. CANADA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2023 (USD MILLION)
• TABLE 76. CANADA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2024-2030 (USD MILLION)
• TABLE 77. CANADA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 78. CANADA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 79. CANADA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 80. CANADA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 81. MEXICO CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2023 (USD MILLION)
• TABLE 82. MEXICO CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2024-2030 (USD MILLION)
• TABLE 83. MEXICO CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2023 (USD MILLION)
• TABLE 84. MEXICO CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2024-2030 (USD MILLION)
• TABLE 85. MEXICO CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2023 (USD MILLION)
• TABLE 86. MEXICO CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2024-2030 (USD MILLION)
• TABLE 87. MEXICO CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 88. MEXICO CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 89. MEXICO CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 90. MEXICO CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 91. UNITED STATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2023 (USD MILLION)
• TABLE 92. UNITED STATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2024-2030 (USD MILLION)
• TABLE 93. UNITED STATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2023 (USD MILLION)
• TABLE 94. UNITED STATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2024-2030 (USD MILLION)
• TABLE 95. UNITED STATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2023 (USD MILLION)
• TABLE 96. UNITED STATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2024-2030 (USD MILLION)
• TABLE 97. UNITED STATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 98. UNITED STATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 99. UNITED STATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 100. UNITED STATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 101. UNITED STATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
• TABLE 102. UNITED STATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
• TABLE 103. ASIA-PACIFIC CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2023 (USD MILLION)
• TABLE 104. ASIA-PACIFIC CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2024-2030 (USD MILLION)
• TABLE 105. ASIA-PACIFIC CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2023 (USD MILLION)
• TABLE 106. ASIA-PACIFIC CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2024-2030 (USD MILLION)
• TABLE 107. ASIA-PACIFIC CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2023 (USD MILLION)
• TABLE 108. ASIA-PACIFIC CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2024-2030 (USD MILLION)
• TABLE 109. ASIA-PACIFIC CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 110. ASIA-PACIFIC CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 111. ASIA-PACIFIC CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 112. ASIA-PACIFIC CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 113. ASIA-PACIFIC CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 114. ASIA-PACIFIC CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 115. AUSTRALIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2023 (USD MILLION)
• TABLE 116. AUSTRALIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2024-2030 (USD MILLION)
• TABLE 117. AUSTRALIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2023 (USD MILLION)
• TABLE 118. AUSTRALIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2024-2030 (USD MILLION)
• TABLE 119. AUSTRALIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2023 (USD MILLION)
• TABLE 120. AUSTRALIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2024-2030 (USD MILLION)
• TABLE 121. AUSTRALIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 122. AUSTRALIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 123. AUSTRALIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 124. AUSTRALIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 125. CHINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2023 (USD MILLION)
• TABLE 126. CHINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2024-2030 (USD MILLION)
• TABLE 127. CHINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2023 (USD MILLION)
• TABLE 128. CHINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2024-2030 (USD MILLION)
• TABLE 129. CHINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2023 (USD MILLION)
• TABLE 130. CHINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2024-2030 (USD MILLION)
• TABLE 131. CHINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 132. CHINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 133. CHINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 134. CHINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 135. INDIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2023 (USD MILLION)
• TABLE 136. INDIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2024-2030 (USD MILLION)
• TABLE 137. INDIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2023 (USD MILLION)
• TABLE 138. INDIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2024-2030 (USD MILLION)
• TABLE 139. INDIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2023 (USD MILLION)
• TABLE 140. INDIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2024-2030 (USD MILLION)
• TABLE 141. INDIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 142. INDIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 143. INDIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 144. INDIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 145. INDONESIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2023 (USD MILLION)
• TABLE 146. INDONESIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2024-2030 (USD MILLION)
• TABLE 147. INDONESIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2023 (USD MILLION)
• TABLE 148. INDONESIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2024-2030 (USD MILLION)
• TABLE 149. INDONESIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2023 (USD MILLION)
• TABLE 150. INDONESIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2024-2030 (USD MILLION)
• TABLE 151. INDONESIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 152. INDONESIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 153. INDONESIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 154. INDONESIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 155. JAPAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2023 (USD MILLION)
• TABLE 156. JAPAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2024-2030 (USD MILLION)
• TABLE 157. JAPAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2023 (USD MILLION)
• TABLE 158. JAPAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2024-2030 (USD MILLION)
• TABLE 159. JAPAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2023 (USD MILLION)
• TABLE 160. JAPAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2024-2030 (USD MILLION)
• TABLE 161. JAPAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 162. JAPAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 163. JAPAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 164. JAPAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 165. MALAYSIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2023 (USD MILLION)
• TABLE 166. MALAYSIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2024-2030 (USD MILLION)
• TABLE 167. MALAYSIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2023 (USD MILLION)
• TABLE 168. MALAYSIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2024-2030 (USD MILLION)
• TABLE 169. MALAYSIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2023 (USD MILLION)
• TABLE 170. MALAYSIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2024-2030 (USD MILLION)
• TABLE 171. MALAYSIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 172. MALAYSIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 173. MALAYSIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 174. MALAYSIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 175. PHILIPPINES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2023 (USD MILLION)
• TABLE 176. PHILIPPINES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2024-2030 (USD MILLION)
• TABLE 177. PHILIPPINES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2023 (USD MILLION)
• TABLE 178. PHILIPPINES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2024-2030 (USD MILLION)
• TABLE 179. PHILIPPINES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2023 (USD MILLION)
• TABLE 180. PHILIPPINES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2024-2030 (USD MILLION)
• TABLE 181. PHILIPPINES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 182. PHILIPPINES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 183. PHILIPPINES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 184. PHILIPPINES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 185. SINGAPORE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2023 (USD MILLION)
• TABLE 186. SINGAPORE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2024-2030 (USD MILLION)
• TABLE 187. SINGAPORE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2023 (USD MILLION)
• TABLE 188. SINGAPORE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2024-2030 (USD MILLION)
• TABLE 189. SINGAPORE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2023 (USD MILLION)
• TABLE 190. SINGAPORE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2024-2030 (USD MILLION)
• TABLE 191. SINGAPORE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 192. SINGAPORE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 193. SINGAPORE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 194. SINGAPORE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 195. SOUTH KOREA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2023 (USD MILLION)
• TABLE 196. SOUTH KOREA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2024-2030 (USD MILLION)
• TABLE 197. SOUTH KOREA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2023 (USD MILLION)
• TABLE 198. SOUTH KOREA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2024-2030 (USD MILLION)
• TABLE 199. SOUTH KOREA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2023 (USD MILLION)
• TABLE 200. SOUTH KOREA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2024-2030 (USD MILLION)
• TABLE 201. SOUTH KOREA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 202. SOUTH KOREA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 203. SOUTH KOREA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 204. SOUTH KOREA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 205. TAIWAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2023 (USD MILLION)
• TABLE 206. TAIWAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2024-2030 (USD MILLION)
• TABLE 207. TAIWAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2023 (USD MILLION)
• TABLE 208. TAIWAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2024-2030 (USD MILLION)
• TABLE 209. TAIWAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2023 (USD MILLION)
• TABLE 210. TAIWAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2024-2030 (USD MILLION)
• TABLE 211. TAIWAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 212. TAIWAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 213. TAIWAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 214. TAIWAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 215. THAILAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2023 (USD MILLION)
• TABLE 216. THAILAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2024-2030 (USD MILLION)
• TABLE 217. THAILAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2023 (USD MILLION)
• TABLE 218. THAILAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2024-2030 (USD MILLION)
• TABLE 219. THAILAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2023 (USD MILLION)
• TABLE 220. THAILAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2024-2030 (USD MILLION)
• TABLE 221. THAILAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 222. THAILAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 223. THAILAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 224. THAILAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 225. VIETNAM CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2023 (USD MILLION)
• TABLE 226. VIETNAM CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2024-2030 (USD MILLION)
• TABLE 227. VIETNAM CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2023 (USD MILLION)
• TABLE 228. VIETNAM CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2024-2030 (USD MILLION)
• TABLE 229. VIETNAM CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2023 (USD MILLION)
• TABLE 230. VIETNAM CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2024-2030 (USD MILLION)
• TABLE 231. VIETNAM CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 232. VIETNAM CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 233. VIETNAM CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 234. VIETNAM CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 235. EUROPE, MIDDLE EAST & AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2023 (USD MILLION)
• TABLE 236. EUROPE, MIDDLE EAST & AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2024-2030 (USD MILLION)
• TABLE 237. EUROPE, MIDDLE EAST & AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2023 (USD MILLION)
• TABLE 238. EUROPE, MIDDLE EAST & AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2024-2030 (USD MILLION)
• TABLE 239. EUROPE, MIDDLE EAST & AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2023 (USD MILLION)
• TABLE 240. EUROPE, MIDDLE EAST & AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2024-2030 (USD MILLION)
• TABLE 241. EUROPE, MIDDLE EAST & AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 242. EUROPE, MIDDLE EAST & AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 243. EUROPE, MIDDLE EAST & AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 244. EUROPE, MIDDLE EAST & AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 245. EUROPE, MIDDLE EAST & AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 246. EUROPE, MIDDLE EAST & AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 247. DENMARK CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2023 (USD MILLION)
• TABLE 248. DENMARK CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2024-2030 (USD MILLION)
• TABLE 249. DENMARK CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2023 (USD MILLION)
• TABLE 250. DENMARK CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2024-2030 (USD MILLION)
• TABLE 251. DENMARK CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2023 (USD MILLION)
• TABLE 252. DENMARK CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2024-2030 (USD MILLION)
• TABLE 253. DENMARK CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 254. DENMARK CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 255. DENMARK CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 256. DENMARK CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 257. EGYPT CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2023 (USD MILLION)
• TABLE 258. EGYPT CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2024-2030 (USD MILLION)
• TABLE 259. EGYPT CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2023 (USD MILLION)
• TABLE 260. EGYPT CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2024-2030 (USD MILLION)
• TABLE 261. EGYPT CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2023 (USD MILLION)
• TABLE 262. EGYPT CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2024-2030 (USD MILLION)
• TABLE 263. EGYPT CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 264. EGYPT CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 265. EGYPT CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 266. EGYPT CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 267. FINLAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2023 (USD MILLION)
• TABLE 268. FINLAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2024-2030 (USD MILLION)
• TABLE 269. FINLAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2023 (USD MILLION)
• TABLE 270. FINLAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2024-2030 (USD MILLION)
• TABLE 271. FINLAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2023 (USD MILLION)
• TABLE 272. FINLAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2024-2030 (USD MILLION)
• TABLE 273. FINLAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 274. FINLAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 275. FINLAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 276. FINLAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 277. FRANCE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2023 (USD MILLION)
• TABLE 278. FRANCE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2024-2030 (USD MILLION)
• TABLE 279. FRANCE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2023 (USD MILLION)
• TABLE 280. FRANCE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2024-2030 (USD MILLION)
• TABLE 281. FRANCE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2023 (USD MILLION)
• TABLE 282. FRANCE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2024-2030 (USD MILLION)
• TABLE 283. FRANCE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 284. FRANCE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 285. FRANCE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 286. FRANCE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 287. GERMANY CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2023 (USD MILLION)
• TABLE 288.

[190 Pages Report] The Cartilage Repair/Cartilage Regeneration Market size was estimated at USD 1.83 billion in 2023 and expected to reach USD 2.06 billion in 2024, at a CAGR 13.55% to reach USD 4.46 billion by 2030.

Cartilage repair and regeneration refers to a range of medical treatments and procedures aimed at restoring function and relieving pain in damaged joint cartilage. Cartilage is a resilient and smooth elastic tissue. This rubber-like padding covers and protects the ends of long bones at the joints and is a structural component of the rib cage, the ear, the nose, the bronchial tubes, the intervertebral discs, and many other body components. The cartilage repair/regeneration market encompasses medical procedures, tools, and treatments designed to repair, regenerate, or replace damaged cartilage. The prevalence of bone and joint disorders such as arthritis or osteoarthritis and the surge in the number of road accidents and sports-related injuries are driving the market growth. Rising awareness about cartilage physiology, anatomy, and repair techniques is also a fuel market. The costs associated with cartilage repair surgeries and the risks and complications involved in cartilage repair/regeneration procedures are restricting market development. Technological advancements in cartilage regeneration equipment are enhancing the efficacy of regenerative treatments. In addition, continuous research and development for cartilage regeneration are expanding its growth potential.

Treatment Mode: Significant preference cell-based therapies for younger patients

Cell-based therapies involve using living cells to repair or regenerate cartilage tissue. These treatments often utilize chondrocytes or mesenchymal stem cells that can differentiate into cartilage cells. Cell-based chondrocyte transplantation represents an advanced medical treatment for cartilage defects and damage, typically employed in patients with localized cartilage loss. This process involves harvesting healthy cartilage cells from the patient's body, laboratory expansion of these cells, and subsequent reimplantation into the damaged area. Growth factor technology involves applying specific proteins known to enhance the growth and differentiation of cells, including chondrocytes. These biological molecules can be delivered through various methods, such as injections or embedded within scaffolds. On the other hand, non-cell-based therapies include treatments that do not directly involve living cells, such as tissue scaffolds and growth factors that aid in the natural process of cartilage repair. Cell-free composites are biomaterials that enable cartilage tissue regeneration without the direct use of living cells. Instead, these materials are engineered to mimic the extracellular matrix and support the migration and proliferation of native cells to the defect site. Tissue scaffolds are 3D structures that provide a supportive environment for the growth and development of new cartilage tissue. These scaffolds can be biodegradable or non-biodegradable and may be made from various materials, including natural and synthetic polymers, ceramics, or composites.

Application: Wider use of hyaline cartilage therapies for efficient joint movement

Fibrocartilage is a tough, dense, and fibrous type of cartilage tissue found in areas of the body, such as the intervertebral discs, menisci, and pubic symphysis. Various proportions of white fibrous tissue and cartilaginous tissue characterize it. Due to its high tensile strength and limited blood supply, fibrocartilage has limited intrinsic healing capability, which necessitates the development of specialized repair techniques. Hyaline cartilage is a transparent, glossy articular cartilage that protects the bones in joints. It provides a smooth, low-friction surface for joint movement and helps to distribute load effectively. Damage to hyaline cartilage can lead to joint pain, stiffness, and conditions like osteoarthritis. Its avascular nature poses significant challenges for repair and regeneration. When comparing fibrocartilage and hyaline cartilage repair, it is evident that both require distinct approaches due to their anatomical and functional differences. While fibrocartilage is more fibrous and is found in fewer body regions, hyaline cartilage is prevalent in all synovial joints and is critical for joint function. Fibrocartilage injuries are commonly associated with specific sites, such as the knee and pelvic region, instead of hyaline cartilage issues, which can affect many joints.

End-User: Rising application of cartilage repair/cartilage regeneration in hospital settings due to presence of advanced equipment and materials needed for the complex procedures

Ambulatory surgery centers(ASCs) are healthcare establishments that deliver same-day surgical care, including diagnostic and preventive procedures. In cartilage repair and regeneration, ASCs are an increasingly popular choice for patients due to their cost-effectiveness and convenience. Clinics, including those specialized, such as orthopedic or sports medicine clinics, offer outpatient cartilage repair and regeneration services. These facilities often provide a more personalized approach to patient care due to their smaller scale than hospitals. Hospitals are comprehensive medical facilities that offer a wide range of healthcare services, including complex surgeries required for advanced cartilage repair and regeneration. Ambulatory Surgery Centers offer efficient and cost-effective solutions for minor procedures, Clinics provide personalized and non-invasive treatments, and Hospitals are equipped for comprehensive care and complex surgeries. Collaborations among providers and manufacturers continue to drive technological advancements and improve patient outcomes in all these healthcare settings.

Regional Insights

The United States leads the region in the adoption of innovative cartilage repair solutions due to well-established healthcare infrastructure, favorable reimbursement scenarios, and the presence of key market players. Countries such as Brazil and Mexico also show potential for market growth, albeit with challenges such as resource limitations in healthcare settings and less favorable reimbursement environments. The Asia-Pacific region is rapidly emerging as a significant cartilage repair and regeneration player. This growth is propelled by increasing disposable incomes, an expanding healthcare sector, growing awareness about cartilage regeneration procedures, and the rising prevalence of lifestyle-related joint disorders. Europe is a major EMEA cartilage repair/regeneration market region, supported by sophisticated healthcare systems, high healthcare expenditure, and strong regulatory frameworks. The presence of leading healthcare companies and substantial investments in research and development fosters innovation in cartilage repair therapies. In contrast, the Middle East and Africa exhibit slower growth with significant healthcare access and quality disparities.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Cartilage Repair/Cartilage Regeneration Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Cartilage Repair/Cartilage Regeneration Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Cartilage Repair/Cartilage Regeneration Market, highlighting leading vendors and their innovative profiles. These include Anika Therapeutics Inc., Arthrex GmbH, B. Braun SE, Collagen Solutions Ltd., CONMED Corporation, Geistlich Pharma AG, Medical Device Business Services, Inc., MEDIPOST Co., Ltd., Orthocell Ltd., Regrow Biosciences Pvt Ltd., RTI Surgical, Inc., Smith & Nephew PLC, Stryker Corporation, Vericel Corporation, and Zimmer Biomet Holdings, Inc..

Market Segmentation & Coverage

This research report categorizes the Cartilage Repair/Cartilage Regeneration Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Treatment Mode
  • Cell-Based
    • Chondrocyte Transplantation
    • Growth Factor Technology

• Non-Cell-Based
  • Cell-Free Composites
  • Tissue Scaffolds
• Application
  • Fibrocartilage
  • Hyaline Cartilage

• End-User
  • Ambulatory Surgery Centers
  • Clinics
  • Hospitals

• Region
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam

• Europe, Middle East & Africa
  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Cartilage Repair/Cartilage Regeneration Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Cartilage Repair/Cartilage Regeneration Market?

3. What are the technology trends and regulatory frameworks in the Cartilage Repair/Cartilage Regeneration Market?

4. What is the market share of the leading vendors in the Cartilage Repair/Cartilage Regeneration Market?

5. Which modes and strategic moves are suitable for entering the Cartilage Repair/Cartilage Regeneration Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Prevalence of bone and joint disorders such as arthritis or osteoarthritis
    • 5.1.1.2. Surge in number of road accidents and sports-related injuries
    • 5.1.1.3. Rising awareness about cartilage physiology, anatomy, and repair techniques
  • 5.1.2. Restraints
    • 5.1.2.1. High costs associated with cartilage repair surgeries
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological advancements in cartilage regeneration equipment
    • 5.1.3.2. Continuous research and development for cartilage regeneration
  • 5.1.4. Challenges
    • 5.1.4.1. Risks and complications involved in cartilage repair/cartilage regeneration procedures
• 5.2. Market Segmentation Analysis
  • 5.2.1. Treatment Mode: Significant preference cell-based therapies for younger patients
  • 5.2.2. Application: Wider use of hyaline cartilage therapies for efficient joint movement
  • 5.2.3. End-User: Rising application of cartilage repair/cartilage regeneration in hospital settings due to presence of advanced equipment and materials needed for the complex procedures
• 5.3. Market Disruption Analysis
• 5.4. Porter's Five Forces Analysis
  • 5.4.1. Threat of New Entrants
  • 5.4.2. Threat of Substitutes
  • 5.4.3. Bargaining Power of Customers
  • 5.4.4. Bargaining Power of Suppliers
  • 5.4.5. Industry Rivalry
• 5.5. Value Chain & Critical Path Analysis
• 5.6. Pricing Analysis
• 5.7. Technology Analysis
• 5.8. Patent Analysis
• 5.9. Trade Analysis
• 5.10. Regulatory Framework Analysis

6. Cartilage Repair/Cartilage Regeneration Market, by Treatment Mode

• 6.1. Introduction
• 6.2. Cell-Based
• 6.3. Non-Cell-Based

7. Cartilage Repair/Cartilage Regeneration Market, by Application

• 7.1. Introduction
• 7.2. Fibrocartilage
• 7.3. Hyaline Cartilage

8. Cartilage Repair/Cartilage Regeneration Market, by End-User

• 8.1. Introduction
• 8.2. Ambulatory Surgery Centers
• 8.3. Clinics
• 8.4. Hospitals

9. Americas Cartilage Repair/Cartilage Regeneration Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Cartilage Repair/Cartilage Regeneration Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Cartilage Repair/Cartilage Regeneration Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. Smith+Nephew acquires novel cartilage regeneration technology for sports medicine knee repair
  • 12.3.2. FDA approves CartiHeal's Implant for the Treatment of Cartilage and Osteochondral Defects
• 12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

• 13.1. Key Company Profiles
• 13.2. Key Product Portfolio